Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephritis, Hereditary | 3 | 2022 | 23 | 1.870 |
Why?
|
| Kidney | 9 | 2023 | 1335 | 1.250 |
Why?
|
| Urogenital Abnormalities | 3 | 2023 | 168 | 1.130 |
Why?
|
| Intellectual Disability | 8 | 2025 | 1093 | 1.110 |
Why?
|
| Urinary Tract | 3 | 2023 | 67 | 0.980 |
Why?
|
| Kidney Diseases | 2 | 2020 | 492 | 0.950 |
Why?
|
| Mitochondrial Diseases | 3 | 2025 | 148 | 0.940 |
Why?
|
| Hematuria | 2 | 2022 | 55 | 0.770 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2019 | 41 | 0.630 |
Why?
|
| Mutation | 12 | 2025 | 6250 | 0.630 |
Why?
|
| Phenotype | 15 | 2025 | 4544 | 0.590 |
Why?
|
| DNA-Directed DNA Polymerase | 2 | 2025 | 92 | 0.590 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 258 | 0.570 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 231 | 0.570 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2023 | 87 | 0.530 |
Why?
|
| Collagen Type IV | 2 | 2022 | 22 | 0.520 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 686 | 0.470 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2025 | 3355 | 0.450 |
Why?
|
| DNA Copy Number Variations | 2 | 2025 | 1034 | 0.380 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2024 | 549 | 0.380 |
Why?
|
| Microcephaly | 3 | 2024 | 354 | 0.380 |
Why?
|
| Child | 21 | 2025 | 25779 | 0.370 |
Why?
|
| Muscle Weakness | 1 | 2012 | 93 | 0.350 |
Why?
|
| Muscular Atrophy | 1 | 2012 | 90 | 0.350 |
Why?
|
| Genetic Testing | 5 | 2024 | 1097 | 0.350 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 112 | 0.340 |
Why?
|
| Cataract | 1 | 2012 | 169 | 0.330 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2024 | 461 | 0.330 |
Why?
|
| Ovary | 1 | 2012 | 372 | 0.310 |
Why?
|
| Humans | 41 | 2025 | 132049 | 0.290 |
Why?
|
| Genotype | 4 | 2025 | 2706 | 0.290 |
Why?
|
| Pedigree | 4 | 2022 | 1724 | 0.290 |
Why?
|
| Exome | 4 | 2019 | 1085 | 0.280 |
Why?
|
| beta-Thalassemia | 2 | 2007 | 30 | 0.280 |
Why?
|
| Bone Density | 3 | 2007 | 369 | 0.280 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 3 | 2010 | 16 | 0.270 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2024 | 578 | 0.250 |
Why?
|
| Female | 26 | 2025 | 70672 | 0.250 |
Why?
|
| Cardiac Output, Low | 1 | 2006 | 62 | 0.240 |
Why?
|
| Adolescent | 12 | 2021 | 20513 | 0.240 |
Why?
|
| Edema | 1 | 2006 | 147 | 0.230 |
Why?
|
| Mutation, Missense | 4 | 2025 | 937 | 0.220 |
Why?
|
| Epilepsy | 2 | 2023 | 891 | 0.220 |
Why?
|
| Arginine-tRNA Ligase | 1 | 2024 | 9 | 0.220 |
Why?
|
| Male | 23 | 2025 | 64891 | 0.210 |
Why?
|
| Kidney Failure, Chronic | 3 | 2019 | 901 | 0.200 |
Why?
|
| Zinc | 1 | 2004 | 140 | 0.200 |
Why?
|
| Gene Duplication | 1 | 2025 | 371 | 0.200 |
Why?
|
| Age of Onset | 4 | 2012 | 626 | 0.200 |
Why?
|
| Seizures | 3 | 2024 | 897 | 0.190 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2025 | 379 | 0.190 |
Why?
|
| Child, Preschool | 10 | 2021 | 14821 | 0.190 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2022 | 35 | 0.190 |
Why?
|
| Autoantigens | 1 | 2022 | 110 | 0.180 |
Why?
|
| Developmental Disabilities | 3 | 2025 | 748 | 0.180 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2024 | 79 | 0.180 |
Why?
|
| Exons | 2 | 2025 | 808 | 0.180 |
Why?
|
| Nephrectomy | 1 | 2022 | 180 | 0.180 |
Why?
|
| Haploinsufficiency | 2 | 2021 | 270 | 0.180 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2021 | 22 | 0.180 |
Why?
|
| Purpura | 1 | 2021 | 26 | 0.170 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2021 | 19 | 0.170 |
Why?
|
| Genes, Recessive | 2 | 2019 | 195 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2021 | 122 | 0.170 |
Why?
|
| Spectrin | 1 | 2021 | 62 | 0.170 |
Why?
|
| Infant | 10 | 2025 | 13113 | 0.160 |
Why?
|
| Young Adult | 5 | 2021 | 9934 | 0.160 |
Why?
|
| Caribbean Region | 1 | 2019 | 20 | 0.160 |
Why?
|
| Nephrons | 1 | 2019 | 19 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 1809 | 0.150 |
Why?
|
| DNA Polymerase gamma | 2 | 2025 | 20 | 0.150 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 99 | 0.150 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2019 | 7 | 0.150 |
Why?
|
| beta Catenin | 1 | 2020 | 227 | 0.150 |
Why?
|
| Xenopus laevis | 1 | 2019 | 125 | 0.150 |
Why?
|
| Leigh Disease | 1 | 2019 | 24 | 0.150 |
Why?
|
| Abnormalities, Multiple | 1 | 2025 | 968 | 0.150 |
Why?
|
| Kidney Transplantation | 1 | 2024 | 568 | 0.150 |
Why?
|
| RNA Helicases | 1 | 2019 | 70 | 0.150 |
Why?
|
| Biopsy | 1 | 2022 | 1287 | 0.150 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 146 | 0.140 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 1055 | 0.140 |
Why?
|
| Drosophila Proteins | 1 | 2024 | 769 | 0.140 |
Why?
|
| Homozygote | 1 | 2019 | 548 | 0.140 |
Why?
|
| Denys-Drash Syndrome | 1 | 2017 | 5 | 0.140 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 658 | 0.140 |
Why?
|
| WT1 Proteins | 1 | 2017 | 24 | 0.140 |
Why?
|
| Autistic Disorder | 1 | 2021 | 379 | 0.140 |
Why?
|
| Genetic Association Studies | 4 | 2025 | 854 | 0.130 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2017 | 36 | 0.130 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 28 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 30 | 0.130 |
Why?
|
| Databases, Genetic | 1 | 2019 | 499 | 0.130 |
Why?
|
| Muscle Hypotonia | 3 | 2024 | 200 | 0.120 |
Why?
|
| Microfilament Proteins | 2 | 2021 | 287 | 0.120 |
Why?
|
| Adult | 10 | 2024 | 31576 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 703 | 0.110 |
Why?
|
| Osteoporosis | 2 | 2007 | 138 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 387 | 0.110 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 178 | 0.100 |
Why?
|
| Stroke | 1 | 2021 | 1065 | 0.100 |
Why?
|
| Glutarates | 1 | 2012 | 37 | 0.090 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 27 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2016 | 826 | 0.090 |
Why?
|
| Smad4 Protein | 1 | 2011 | 59 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2021 | 2568 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 149 | 0.090 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2010 | 33 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1296 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 827 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2849 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3847 | 0.080 |
Why?
|
| Glycine | 1 | 2010 | 172 | 0.080 |
Why?
|
| Mitral Valve | 1 | 2011 | 256 | 0.080 |
Why?
|
| Brain | 1 | 2021 | 3196 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2012 | 1118 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4676 | 0.070 |
Why?
|
| Hearing Loss | 1 | 2010 | 212 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2025 | 1054 | 0.070 |
Why?
|
| Aorta | 1 | 2011 | 545 | 0.070 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2007 | 58 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2022 | 17308 | 0.060 |
Why?
|
| Heterozygote | 2 | 2021 | 718 | 0.060 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 71 | 0.060 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2006 | 49 | 0.060 |
Why?
|
| Albuminuria | 1 | 2006 | 113 | 0.060 |
Why?
|
| Animals | 3 | 2024 | 35067 | 0.060 |
Why?
|
| Universal Precautions | 1 | 2004 | 4 | 0.060 |
Why?
|
| Sodium | 1 | 2006 | 292 | 0.060 |
Why?
|
| Centrioles | 1 | 2023 | 6 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1829 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 242 | 0.050 |
Why?
|
| Disease Transmission, Infectious | 1 | 2004 | 86 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1960 | 0.050 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2011 | 705 | 0.050 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2023 | 17 | 0.050 |
Why?
|
| Genetic Counseling | 1 | 2024 | 246 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 341 | 0.050 |
Why?
|
| Integrins | 1 | 2023 | 94 | 0.050 |
Why?
|
| Mutant Proteins | 1 | 2023 | 117 | 0.050 |
Why?
|
| Genomics | 2 | 2025 | 1644 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2006 | 1368 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2004 | 293 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2006 | 749 | 0.050 |
Why?
|
| Dogs | 1 | 2023 | 654 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2023 | 610 | 0.040 |
Why?
|
| Iran | 3 | 2007 | 96 | 0.040 |
Why?
|
| Collagen Type V | 1 | 2021 | 4 | 0.040 |
Why?
|
| Cross Infection | 1 | 2004 | 341 | 0.040 |
Why?
|
| Collagen Type III | 1 | 2021 | 26 | 0.040 |
Why?
|
| Time | 1 | 2021 | 99 | 0.040 |
Why?
|
| Problem Behavior | 1 | 2021 | 41 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2004 | 388 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 76 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2010 | 5370 | 0.040 |
Why?
|
| Dwarfism | 1 | 2021 | 104 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 160 | 0.040 |
Why?
|
| Face | 1 | 2021 | 189 | 0.040 |
Why?
|
| Drosophila | 1 | 2024 | 825 | 0.040 |
Why?
|
| Alleles | 1 | 2024 | 1681 | 0.040 |
Why?
|
| Calcium | 1 | 2004 | 1074 | 0.040 |
Why?
|
| Proteins | 1 | 2023 | 1067 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2004 | 886 | 0.030 |
Why?
|
| Retina | 1 | 2020 | 493 | 0.030 |
Why?
|
| Pleckstrin Homology Domains | 1 | 2016 | 2 | 0.030 |
Why?
|
| Gestational Age | 1 | 2021 | 1225 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 1410 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2021 | 905 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 463 | 0.030 |
Why?
|
| Hypertension, Renal | 1 | 2005 | 35 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2016 | 201 | 0.030 |
Why?
|
| Urine | 1 | 2005 | 92 | 0.030 |
Why?
|
| Proteinuria | 1 | 2005 | 108 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 564 | 0.030 |
Why?
|
| United States | 1 | 2010 | 11620 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2019 | 8501 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2014 | 127 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 3977 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 2062 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 64 | 0.030 |
Why?
|
| Pregnancy | 1 | 2006 | 7552 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2013 | 251 | 0.020 |
Why?
|
| Fibrillins | 1 | 2011 | 31 | 0.020 |
Why?
|
| Fibrillin-1 | 1 | 2011 | 62 | 0.020 |
Why?
|
| Genotyping Techniques | 1 | 2011 | 110 | 0.020 |
Why?
|
| Intestinal Polyposis | 1 | 2011 | 18 | 0.020 |
Why?
|
| Fetus | 1 | 2014 | 600 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 317 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 570 | 0.020 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2011 | 74 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2011 | 362 | 0.020 |
Why?
|
| Marfan Syndrome | 1 | 2011 | 150 | 0.020 |
Why?
|
| Mass Screening | 1 | 2005 | 827 | 0.020 |
Why?
|
| Disease Progression | 1 | 2005 | 2228 | 0.020 |
Why?
|
| Trinucleotide Repeats | 1 | 2008 | 109 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2008 | 248 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1501 | 0.020 |
Why?
|
| DNA | 1 | 2011 | 1529 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 18575 | 0.010 |
Why?
|
| Middle Aged | 4 | 2008 | 28827 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2010 | 985 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2007 | 207 | 0.010 |
Why?
|
| Obesity | 1 | 2016 | 2408 | 0.010 |
Why?
|
| Creatinine | 1 | 2006 | 414 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 3421 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2008 | 1539 | 0.010 |
Why?
|
| Survivors | 1 | 2006 | 356 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 1444 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 1350 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2004 | 205 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 2921 | 0.010 |
Why?
|
| Aged | 3 | 2008 | 21317 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 10834 | 0.010 |
Why?
|
| Prevalence | 1 | 2007 | 2659 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 5142 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 1442 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 1708 | 0.010 |
Why?
|
| Hypertension | 1 | 2006 | 1341 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2004 | 6509 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 7097 | 0.010 |
Why?
|